Pacira Pharma (PCRX) Tops Q3 EPS by 7c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Pacira Pharma (PCRX) Tops Q3 EPS by 7c

Pacira BioSciences Reports Third Quarter 2021 Financial Results

November 3, 2021 8:00 AM EDT

-- Third quarter GAAP net income of $17.7 million and adjusted EBITDA of $48.1 million --

-- Conference call today at 8:30 a.m. ET --

TAMPA, Fla., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today reported financial results for the third quarter of 2021.

Third Quarter 2021 Financial Highlights

Total revenues of $127.7 millionGAAP net income of $17.7 million, or $0.40 per share... More